Senator Richard Burr Sold D.C. Townhouse to Lobbyist and Donor

Senator Richard Burr (R-N.C.) was found to have sold his Washington D.C. townhouse in 2017 to a lobbyist who had donated to his campaigns, and who had business before the Senate Intelligence Committee that he chairs, according to The Hill.

The report originally comes from the left-wing organization ProPublica, which found that Burr sold the townhouse to lobbyist John Green for the price of $900,000, which may have been above the market value price of around $800,000. The sale was also done off-market.

Green, in addition to lobbying on behalf of such industries as Big Pharma and the National Rifle Association, has also donated to Senator Burr’s campaigns in the past, including hosting at least one fundraiser for him. Green and his lobbying firm plan to use the townhouse as an office to serve as a base of operations in D.C. Both Burr and Green denied any impropriety behind the sale.

Burr had also come under heavy fire when it was revealed that he, alongside several other senators including Kelly Loefler (R-Ga.) and Dianne Feinstein (D-Calif.), had sold hundreds of thousands of dollars’ worth of stock after a confidential briefing informing the Senate of the coming economic collapse due to the spread of the coronavirus, which would amount to an act of insider trading.

About Eric Lendrum

Eric Lendrum graduated from the University of California, Santa Barbara, where he was the Secretary of the College Republicans and the founding chairman of the school’s Young Americans for Freedom chapter. He has interned for Young America’s Foundation, the Heritage Foundation, and the White House, and has worked for numerous campaigns including the 2018 re-election of Congressman Devin Nunes (CA-22).

Photo: (Photo by Mark Wilson/Getty Images)

Content created by the Center for American Greatness, Inc. is available without charge to any eligible news publisher that can provide a significant audience. For licensing opportunities for our original content, please contact

Want news updates?

Sign up for our newsletter to stay up to date.